Accounts Payable, Current of Kuvatris Therapeutics, Inc. from 31 Dec 2021 to 30 Sep 2024

Taxonomy & unit: us-gaap: USD
Description: Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary: Kuvatris Therapeutics, Inc. quarterly Accounts Payable, Current in USD history and change rate from 31 Dec 2021 to 30 Sep 2024.
Kuvatris Therapeutics, Inc. Accounts Payable, Current for the quarter ending 30 Sep 2024 was $2,145,739.
Source SEC data: View on sec.gov

Accounts Payable, Current, Quarterly (USD)

Accounts Payable, Current, YoY Quarterly Change (%)

Kuvatris Therapeutics, Inc. Quarterly Accounts Payable, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2024	$2,145,739			30 Sep 2024	10-Q	14 Jan 2026	2024	Q3
Q2 2024	$2,042,103			30 Jun 2024	10-Q	20 Sep 2024	2024	Q2
Q4 2023	$830,233	+$108,278	+15%	31 Dec 2023	10-Q	14 Jan 2026	2024	Q3
Q1 2023	$480,211			31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	$721,955	-$14,296	-1.9%	31 Dec 2022	10-Q	15 May 2023	2023	Q1
Q3 2022	$2,688,533			30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q2 2022	$2,163,419			30 Jun 2022	10-Q	30 Sep 2022	2022	Q2
Q4 2021	$736,251			31 Dec 2021	10-K	30 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.